... Continue to: https://youtube.com/shorts/8e36ZdFiDDI?si=KGEQue3ITQecT3Cf
♨️ Hot off the press: Researchers at #CharitéBerlin & FMP have developed a fundamentally new therapeutic approach to the hereditary disease #CysticFibrosis! They succeeded in repairing the causal cell defect with a #nanobody – a tiny antibody fragment – in the lab.
#CharitéPaper #CharitéPediatrics #CF #CysticFibrosis #medicine #research #science #chemistry #MedMastodon #ScienceMastodon #pharmacology
New paper out: Meet Psysol 3—a novel #cyclotide #NaturalProduct from Psychotria solitudinum. A #cystine_knot #peptide that potently inhibits prolyl oligopeptidase, expanding chemical space for POP #pharmacology and #DrugDiscovery. #ChemicalBiology @univienna #PeptAIDes #ZK81B @fwf

Peptides from natural sources have often served as valuable leads in drug discovery. Plant-derived protease inhibitors are a notable class, yet their distribution, diversity, and targets remain underexplored. Here, eleven tropical Psychotria species were screened for cyclic cysteine-rich peptides, with extracts showing concentration-dependent inhibition of human prolyl oligopeptidase (POP). Peptidomics combining mass spectrometry and transcriptome mining revealed multiple inhibitory peptides. From Psychotria solitudinum, which contained 37 peptides, a novel peptide (psysol 3) was purified and sequenced. Its synthetic analogue inhibited POP with an IC50 of ~ 1.3 µM. Sequence analysis and synthetic probes identified loop 3 as the inhibitory motif. Psysol 3 is a new probe for POP pharmacology and future structure–activity studies.